BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3277904)

  • 1. Treatment of early chronic lymphocytic leukemia: intermittent chlorambucil versus observation.
    Shustik C; Mick R; Silver R; Sawitsky A; Rai K; Shapiro L
    Hematol Oncol; 1988; 6(1):7-12. PubMed ID: 3277904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of CLL patients after chlorambucil therapy. Special value of a second RAI staging.
    Michallet M; Sotto JJ; Moulin JJ; Arvieux J; Hollard D
    Eur J Cancer (1965); 1980 Apr; 16(4):511-7. PubMed ID: 7398721
    [No Abstract]   [Full Text] [Related]  

  • 3. Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia.
    Dighiero G; Maloum K; Desablens B; Cazin B; Navarro M; Leblay R; Leporrier M; Jaubert J; Lepeu G; Dreyfus B; Binet JL; Travade P
    N Engl J Med; 1998 May; 338(21):1506-14. PubMed ID: 9593789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of daily versus intermittent chlorambucil and prednisone therapy in the treatment of patients with chronic lymphocytic leukemia.
    Sawitsky A; Rai KR; Glidewell O; Silver RT
    Blood; 1977 Dec; 50(6):1049-59. PubMed ID: 336116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic and therapeutic advances in CLL management: the experience of the French Cooperative Group. French Cooperative Group on Chronic Lymphocytic Leukemia.
    Semin Hematol; 1987 Oct; 24(4):275-90. PubMed ID: 3317854
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of chronic lymphocytic leukemia in advanced stages. A randomized trial comparing chlorambucil plus prednisone versus cyclophosphamide, vincristine, and prednisone.
    Montserrat E; Alcalá A; Parody R; Domingo A; García-Conde J; Bueno J; Ferrán C; Sanz MA; Giralt M; Rubio D
    Cancer; 1985 Nov; 56(10):2369-75. PubMed ID: 3899346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of "CHOP" regimen in advanced untreated chronic lymphocytic leukaemia. French Cooperative Group on Chronic Lymphocytic Leukaemia.
    Lancet; 1986 Jun; 1(8494):1346-9. PubMed ID: 2872470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient accrual and interim statistical analysis in long-term randomized clinical trials: the French chronic lymphocytic leukemia CLL 80 protocol as a case study.
    Chastang C; Travade P; Benichou J; Dighiero G; Binet JL
    Stat Med; 1986; 5(5):465-73. PubMed ID: 3538262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [KM 2210 therapy for chronic lymphocytic leukemia].
    Mori M; Murai Y; Miwa A; Fukayama M; Ikebuchi K; Nakamura N; Kaise M
    Gan No Rinsho; 1983 Dec; 29(15):1788-90. PubMed ID: 6689433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of chronic lymphocytic leukaemia and well-differentiated lymphocytic lymphoma with continuous low- or intermittent high-dose prednimustine versus chlorambucil/prednisolone.
    Ideström K; Kimby E; Björkholm M; Mellstedt H; Engstedt L; Gahrton G; Johansson B; Killander D; Robérts KH; Stalfelt AM; Udén AM; Wadman B; Wählby S
    Eur J Cancer Clin Oncol; 1982 Nov; 18(11):1117-23. PubMed ID: 6897633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival and prognostic factors in chronic lymphocytic leukemia.
    Pines A; Ben-Bassat I; Modan M; Blumstein T; Ramot B
    Eur J Haematol; 1987 Feb; 38(2):123-30. PubMed ID: 3595807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute lymphoblastic leukemia supervening in a case of chronic lymphocytic leukemia after continuous 3-year treatment with chlorambucil.
    Eridani S; Parry H; Glass U; Greaves M
    Cancer; 1984 Aug; 54(3):397-9. PubMed ID: 6587931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlations between lymphocyte subpopulation and stage of disease in chronic lymphatic leukemia of Rai].
    Heilmann E; Nordiek R
    Haematologia (Budap); 1977; 11(3-4):289-95. PubMed ID: 311309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of chronic lymphocytic leukemia using chlorambucil and prednisone with or without cycle-active consolidation chemotherapy. A Southeastern Cancer Study Group Trial.
    Keller JW; Knospe WH; Raney M; Huguley CM; Johnson L; Bartolucci AA; Omura GA
    Cancer; 1986 Sep; 58(6):1185-92. PubMed ID: 3527402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHOP regimen versus intermittent chlorambucil-prednisone in stage B chronic lymphocytic leukemia. Short term results from a randomized clinical trial. French Cooperative Group on Chronic Lymphocytic Leukemia.
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):449-52. PubMed ID: 2906118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Phase II study of chlorambucil in patients with hematological malignancies].
    Inoue K; Ogawa M; Horikoshi N; Mukaiyama T; Itoh Y; Imajoh K; Ozeki H; Nagamine D; Shinagawa K
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2672-5. PubMed ID: 3307632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy program for patients with advanced stages of chronic lymphocytic leukemia. Chlorambucil, splenectomy, and total lymph node irradiation.
    Pegourie-Bandelier B; Sotto JJ; Hollard D; Bolla M; Sarrazin R
    Cancer; 1995 Jun; 75(12):2853-61. PubMed ID: 7773934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High dose continuous chlorambucil vs intermittent chlorambucil plus prednisone for treatment of B-CLL--IGCI CLL-01 trial.
    Jaksić B; Brugiatelli M
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):437-42. PubMed ID: 3065740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splenectomy during chronic lymphocytic leukemia.
    Pegourie B; Sotto JJ; Hollard D; Michallet M; Sotto MF
    Cancer; 1987 May; 59(9):1626-30. PubMed ID: 3828962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The UK Medical Research Council CLL trials 1 and 2.
    Catovsky D; Fooks J; Richards S
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):423-7. PubMed ID: 3222154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.